| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e5642a93a9558cd2855a54aa5e07777 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-191 |
| filingDate |
2020-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6327632fcf484d65c8bacbe747461c26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25b9239606a3de104eb047826e1f4fda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_049660afc4ea918232cfb8a48c056199
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b24c0a9d08babf78e883296442c0e5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4247acbbc652aad8503dc1cca1037bd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f80364b1680ac0735d101df6914d4d8f |
| publicationDate |
2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202103693-A |
| titleOfInvention |
Vaginal tablet formulation |
| abstract |
The present invention concerns a pharmaceutical composition comprising glucono-[delta]-lactone, which is suitable for use in the treatment of vaginal microbial infections. |
| priorityDate |
2019-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |